These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5474598)

  • 1. [The value of lipavlon in diabetic retinopathy].
    François P; Belervacque A; Turut P
    Bull Soc Ophtalmol Fr; 1970 Apr; 70(4):568-73. PubMed ID: 5474598
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic retinopathy.
    Harrold BP
    Lancet; 1971 Jan; 1(7688):42. PubMed ID: 4099348
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy.
    Harrold BP; Marmion VJ; Gough KR
    Diabetes; 1969 May; 18(5):285-91. PubMed ID: 4894161
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 7. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML; Setty KR; Roy SB
    J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of the effect of ethyl-alpha-p-chlorophenoxybutyrate (clofibrate) in the venous retinal thrombosis].
    Cioli S; Nizzola GM
    Ann Ottalmol Clin Ocul; 1970 Sep; 96(9):477-82. PubMed ID: 5519038
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA; de Bulhões F; Tuma M
    Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum-lipid reducing principles--possibilities for treatment. 6. Indications for the use of clofibrate].
    Gustafson A
    Lakartidningen; 1970 Dec; 67():Suppl IV:75+. PubMed ID: 5511954
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of diabetes insipidus with clofibrate].
    Annee Endocrinol; 1971; 23():101-3. PubMed ID: 5562226
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of exudative diabetic retinopathies with clofibrate (Atromid-S)].
    Houtsmuller AJ
    Ned Tijdschr Geneeskd; 1967 Nov; 111(45):2039-40. PubMed ID: 4863523
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic study of clofibrate during pituitrin-sensitive diabetes insipidus in children].
    de Gennes JL; Desbois JC; Marie J
    Ann Pediatr (Paris); 1970 Nov; 17(11):754-9. PubMed ID: 5484620
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of parachlorophenoxyisobutyric acid (CPIB acid) and of diet on blood cholesterol and on the beta-alpha lipoprotein ratio in aged subjects].
    Bronzini A; Di Gregorio D; Scotti G
    G Gerontol; 1969 Nov; 17(11):1067-75. PubMed ID: 5397791
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
    Cullen JF; Ireland JT; Oliver MF
    Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of arteriosclerosis by Atromid].
    Ayad H
    Rev Med Moyen Orient; 1967; 24(6):504-11. PubMed ID: 5264185
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of essential hyperlipemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of Clofibrate SPOFA in the treatment of diabetic retinopathy].
    Oláh Z
    Cesk Oftalmol; 1971 Sep; 27(5):315-8. PubMed ID: 5110678
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of fenofibrate and clofibrate hypolipidemic effects.
    Daubresse JC
    Acta Clin Belg; 1980; 35(4):227-32. PubMed ID: 7015771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.